New York: Scientists have sequenced genome of a malaria parasite that constitutes about 65 percent malaria cases in India, paving the way for new vaccines to combat the disease. The National Institute of Malaria Research in India was a part of the study which focused on Plasmodium vivax (P.Vivax), a species of malaria that afflicts humans and the most prevalent human malaria parasite outside Africa. P. Vivax malaria constitutes about 60-65 percent of total malaria cases in India. The study was led by Jane Carlton, part of New York University`s Center for Genomics and Systems Biology. "The bad news is there is significantly more genetic variation in P. Vivax than we`d thought, which could make it quite adept at evading whatever arsenal of drugs and vaccines we throw at it," Carlton who is also heading the International Center of Excellence for Malaria Research (ICEMR) based in India. "However, now that we have a better understanding of the challenges we face, we can move forward with a deeper analysis of its genomic variation in pursuing more effective remedies," Carlton said in a statement.
Complete analysis of Modi govt`s maiden budget
Budget growth oriented, says Arun Jaitley
Acting legend Zohra Sehgal dies at 102
We didn`t want to burden the common man: Arun Jaitley on budget